Daisuke Hasegawa   Yuri Yoshimoto   Shunsuke Kimura   Tadashi Kumamoto   Naoko Maeda   Junichi Hara   Atsushi Kikuta   Akiko Kada   Toshimi Kimura   Yuka Iijima-Yamashita   Akiko M Saito   Keizo Horibe   Atsushi Manabe   Chitose Ogawa   
International journal of hematology 110(5) 627-634 2019年11月
Outcomes of children treated for relapsed acute lymphoblastic leukemia (ALL) remain poor. Bortezomib (BZM), a proteasome inhibitor, has shown promising activity against lymphoid malignancies. We conducted a phase I study to evaluate the safety and...